tiprankstipranks
Trending News
More News >
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
US Market
Advertisement

Cidara Therapeutics (CDTX) Technical Analysis

Compare
778 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Cidara Therapeutics’s (CDTX) Moving Averages Convergence Divergence (MACD) indicator is 1.65, suggesting Cidara Therapeutics is a Buy.
Cidara Therapeutics’s (CDTX) 20-Day exponential moving average is 63.66, while Cidara Therapeutics’s (CDTX) share price is $63.17, making it a Sell.
Cidara Therapeutics’s (CDTX) 50-Day exponential moving average is 57.08, while Cidara Therapeutics’s (CDTX) share price is $63.17, making it a Buy.

Cidara Therapeutics (CDTX) Pivot Points

Sep 08, 2025, 08:10 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
58.10
59.54
62.23
63.67
66.36
67.80
70.49
Fibonacci
59.54
61.11
62.09
63.67
65.24
66.22
67.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cidara Therapeutics (CDTX) Moving Averages

Sep 08, 2025, 08:10 AM
Period
Simple
Exponential
MA5
64.14Sell
64.11Sell
MA10
64.88Sell
64.36Sell
MA20
64.20Sell
63.66Sell
MA50
59.42Buy
57.08Buy
MA100
41.57Buy
46.88Buy
MA200
31.47Buy
35.47Buy
Cidara Therapeutics’s (CDTX) 10-Day exponential moving average is 64.36, while Cidara Therapeutics’s (CDTX) share price is $63.17, making it a Sell.
Cidara Therapeutics’s (CDTX) 100-Day exponential moving average is 46.88, while Cidara Therapeutics’s (CDTX) share price is $63.17, making it a Buy.
Cidara Therapeutics’s (CDTX) stock price is $63.17 and Cidara Therapeutics’s (CDTX) 50-day simple moving average is 59.42, creating a Buy signal.
Cidara Therapeutics’s (CDTX) stock price is $63.17 and Cidara Therapeutics’s (CDTX) 100-day simple moving average is 41.57, creating a Buy signal.
Cidara Therapeutics’s (CDTX) stock price is $63.17 and Cidara Therapeutics’s (CDTX) 200-day simple moving average is 31.47, creating a Buy signal.

Cidara Therapeutics (CDTX) Technical Indicators

Sep 08, 2025, 08:10 AM
Name
Value
Implied Action
RSI (14)
51.89
Neutral
STOCH (9,6)
36.71
Neutral
STOCHRSI (14)
42.29
Neutral
MACD (12,26)
1.65
Buy
ADX (14)
32.70
Neutral
Williams %R
-64.75
Buy
CCI (14)
4.22
Neutral
ATR (14)
3.48
-
Ultimate Oscillator
49.41
Neutral
ROC
-3.14
Sell
Cidara Therapeutics’s (CDTX) Relative Strength Index (RSI) is 51.89, creating a Neutral signal.
Cidara Therapeutics’s (CDTX) Trend Strength Indicator (ADX) is 32.70, creating a Neutral signal.
Cidara Therapeutics’s (CDTX) Commodity Channel Index (CCI) is 4.22, creating a Neutral signal.
Cidara Therapeutics’s (CDTX) Price Rate of Change (ROC) is -3.14, creating a Sell signal.

FAQ

Is CDTX a Buy, Hold, or Sell?
Based on CDTX’s technical indicators, CDTX is a Hold.
    What is CDTX’s RSI (14)?
    CDTX’s RSI (14) is 51.89, which suggests CDTX is a Neutral.
      What is CDTX’s MACD?
      CDTX’s MACD is 1.65, which suggests CDTX is a Buy.
        What is CDTX’s 5-day moving average?
        CDTX’s 5-day moving average is 64.14, which suggests CDTX is a Sell.
          What is CDTX’s 20-day moving average?
          CDTX 20-day moving average is 64.20, which suggests CDTX is a Sell.
            What is CDTX’s 50-day moving average?
            CDTX’s 50-day moving average is 59.42, which suggests CDTX is a Buy.
              What is CDTX’s 200-day moving average?
              CDTX’s 200-day moving average is 31.47, which suggests CDTX is a Buy.
                What is CDTX’s Williams % R (14)?
                CDTX’s Williams % R (14) is -64.75, which suggests CDTX is a Buy.
                  What is CDTX’s CCI (14)?
                  CDTX’s CCI (14) is 4.22, which suggests CDTX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis